妇科肿瘤学组在子宫体恶性肿瘤中的临床试验：最新进展。
Gynecologic oncology group trials in uterine corpus malignancies: recent progress.
机构信息
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
出版信息
J Gynecol Oncol. 2008 Dec;19(4):218-22. doi: 10.3802/jgo.2008.19.4.218. Epub 2008 Dec 29.
Abstract
The Gynecologic Oncology Group (GOG) has conducted multiple trials related to malignancies of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced endometrial cancer, whole abdominal irradiation in maximally resected advanced endometrial carcinoma, and combination chemotherapy regimens for stage I and II carcinosarcoma after primary surgery and for advanced or recurrent carcinosarcoma. This article will discuss the background and details of each of these important advances.
摘要
妇科肿瘤学组（GOG）已经开展了多项与子宫体恶性肿瘤相关的临床试验。最近，其中的几项试验已经公布。重点领域包括腹腔镜分期子宫内膜癌的可行性、局部晚期子宫内膜癌的辅助治疗、最大限度切除晚期子宫内膜癌的全腹部放疗，以及Ⅰ期和Ⅱ期癌肉瘤患者手术后和晚期或复发性癌肉瘤患者的联合化疗方案。本文将讨论这些重要进展的背景和细节。
相似文献
1
Gynecologic oncology group trials in uterine corpus malignancies: recent progress.
J Gynecol Oncol. 2008 Dec;19(4):218-22. doi: 10.3802/jgo.2008.19.4.218. Epub 2008 Dec 29.
2
Recent progress: gynecologic oncology group trials in uterine corpus tumors.
Rev Recent Clin Trials. 2009 May;4(2):70-4. doi: 10.2174/157488709788186012.
3
4
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.
Gynecol Oncol. 2007 Nov;107(2):177-85. doi: 10.1016/j.ygyno.2007.07.070. Epub 2007 Sep 5.
5
Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study.
Balkan Med J. 2019 Jul 11;36(4):229-234. doi: 10.4274/balkanmedj.galenos.2019.2018.12.75. Epub 2019 Mar 15.
6
Present status and future direction of clinical trials in advanced endometrial carcinoma.
J Gynecol Oncol. 2008 Sep;19(3):157-61. doi: 10.3802/jgo.2008.19.3.157. Epub 2008 Sep 30.
7
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
J Gynecol Oncol. 2017 Jan;28(1):e12. doi: 10.3802/jgo.2017.28.e12. Epub 2016 Oct 27.
8
[Gynecologic cancer].
Gan To Kagaku Ryoho. 2008 Sep;35(9):1488-94.
9
Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
Aust N Z J Obstet Gynaecol. 2016 Apr;56(2):199-206. doi: 10.1111/ajo.12449. Epub 2016 Feb 18.
10
Gynecological malignancies.
Cancer Chemother Biol Response Modif. 1996;16:564-91.
引用本文的文献
1
Racial and Ethnic Disparities in Gynecologic Carcinosarcoma: A Single-Institution Experience.
Cancers (Basel). 2023 Sep 23;15(19):4690. doi: 10.3390/cancers15194690.
2
The diagnostic value of human epididymis protein 4 for endometrial cancer is moderate.
Sci Rep. 2021 Jan 12;11(1):575. doi: 10.1038/s41598-020-79960-1.
3
Metabolomics for Diagnosis and Prognosis of Uterine Diseases? A Systematic Review.
J Pers Med. 2020 Dec 21;10(4):294. doi: 10.3390/jpm10040294.
4
Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
Technol Cancer Res Treat. 2017 Aug;16(4):435-439. doi: 10.1177/1533034616666644. Epub 2016 Aug 24.
5
Adjuvant chemotherapy for endometrial cancer after hysterectomy.
Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD003175. doi: 10.1002/14651858.CD003175.pub2.
本文引用的文献
1
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.
Gynecol Oncol. 2009 Mar;112(3):543-52. doi: 10.1016/j.ygyno.2008.11.014. Epub 2008 Dec 23.
2
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.
Gynecol Oncol. 2007 Nov;107(2):177-85. doi: 10.1016/j.ygyno.2007.07.070. Epub 2007 Sep 5.
3
Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.
J Clin Oncol. 2007 Feb 10;25(5):526-31. doi: 10.1200/JCO.2006.06.4907.
4
Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study.
Qual Life Res. 2007 Feb;16(1):89-100. doi: 10.1007/s11136-006-9003-5. Epub 2006 Oct 11.
5
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
J Clin Oncol. 2006 Jan 1;24(1):36-44. doi: 10.1200/JCO.2004.00.7617. Epub 2005 Dec 5.
6
Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study.
Am J Obstet Gynecol. 2005 Nov;193(5):1645-9. doi: 10.1016/j.ajog.2005.05.004.
7
Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study.
Gynecol Oncol. 2005 Jun;97(3):755-63. doi: 10.1016/j.ygyno.2005.03.011.
8
Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
Gynecol Oncol. 2005 Mar;96(3):630-4. doi: 10.1016/j.ygyno.2004.11.022.
9
Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
J Clin Oncol. 2004 Oct 1;22(19):3902-8. doi: 10.1200/JCO.2004.02.088.
10
A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
Gynecol Oncol. 2000 Nov;79(2):147-53. doi: 10.1006/gyno.2000.6001.
Zotero 插件